IMMM 2025 Videos
#stroke
Session 1 - Cerebroprotective treatment strategies after stroke – Evidence from 3 new studies - Introduction
Speaker: Jennifer ManzanoInstitution: Head of Asian Hospital and Medical Center – Asian Brain Institute, Metro Manila, Philippines
#stroke
Effect of Cerebrolysin on circulating tight junction proteins after reperfusion therapy
Speaker: Sławomir MichalakInstitution: Institute of Neurological Disorders, Poznan, Poland
#stroke
Cerebroprotection as an adjunct to mechanical thrombectomy
Speaker: Jacek StaszewskiInstitution: Military Institute of Medicine, Warsaw, Poland
Speech therapy combined with a cerebroprotective agent enhances aphasia recovery after AIS: Result from the ESCAS study
Speaker: Micha KarlinskiInstitution: Institute of Psychiatry and Neurology, Warsaw, Poland
#tbi
TBI-consequences – Updates on essential guideline recommendations in neurorehabilitation
Speaker: Sindi MitrovicInstitution: Clinic for rehabilitation “Dr Miroslav Zotović” Belgrade, Serbia
#tbi
Session 2 - Advances in brain trauma treatment strategies - Introduction
Speaker: Paschenelle CelisInstitution: Metro North Medical Center And Hospital Inc., Metro Manila, Philippines
#tbi
Clinical benefits of Cerebrolysin treatment in the real world – remarkable recovery after TBI
Speaker: Philipp LiInstitution: Far Eastern Memorial Hospital, New Taipei City, Taiwan
#tbi
Clinical benefits of Cerebrolysin treatment in the real world – recovery after delirium
Speaker: Adel AlansaryInstitution: Anesthesiology and Critical Care, Faculty of Medicine Ain Shams University, Abbasia-Cairo, Egypt
#stroke
Expert Panel Discussion
Speaker: Dafin Muresanu, Michael Brainin, Daniel Šaňák, Paschenelle Celis, Paola Marangolo, Philipp LiInstitution:
#neurocognitive disorders
Session 3 - New evidence in post-stroke cognition - Introduction
Speaker: Slaven PikijaInstitution: Medical University of Graz, Universitätsklinik für Department of Neurology, Austria
#neurocognitive disorders
CREGS - Results of a large high-quality comparative effectiveness study
Speaker: Michael BraininInstitution: Department for Clinical Neurosciences and Preventive Medicine, Danube University Krems, Austria
#neurocognitive disorders
Cerebrolysin and post stroke cognitive decline – Results from a Mexican retrospective cohort
Speaker: Manuel MartinezInstitution: Neurology Department, Hospital Universitario de la UAdeC, Saltillo, México
#neurocognitive disorders
Post-stroke cognitive assessments – Essentials for the acute and subacute phase
Speaker: Sigrid SchwarzInstitution: Universitätsklinikum Tulln, Austria
#stroke
Speech therapy combined with a cerebroprotective agent enhances aphasia recovery after AIS: Results from the ESCAS study
Speaker: Dafin MuresanuInstitution: Chairman Department of Neurosciences, University of Medicine and Pharmacy ‘Iuliu Hatieganu’, Cluj-Napoca, Romania